Brought to you by

Merck Serono and F-Star to discover new inflammation therapies
08 Dec 2015
Executive Summary
Merck KGAA’s Merck Serono SA and antibody engineering company F-Star GMBH have entered into an agreement to discover new antibody therapeutics for inflammatory diseases.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Large Molecule
- Antibodies
-
Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com